Sept. 17, 2024 -- Endomimetics, the developer of Bionanomatrix™, a peptide-based biomaterial to promote healing and improve outcomes following medical device implantation and other procedures, today announced the awarding of a $2.8 million Phase II Small Business Innovation Research (SBIR) grant to support research to evaluate the potential of Bionanomatrix™ to improve performance of flow diverters used in the treatment of brain aneurysms. This application of Bionanomatrix™ is one of several